Mutation analysis of the M6b gene in patients with Pelizaeus-Merzbacher-like syndrome

Marco Henneke, Lars Erik Wehner, Hans Christian Hennies, Natalie Preuß, Jutta Gärtner

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


"Pelizaeus-Merzbacher-like syndrome" is an undetermined leukodystrophy disorder of diffuse hypomyelination. The patients' clinical phenotype is indistinguishable from classical Pelizaeus-Merzbacher disease (PMD), but the patients lack PLP1 gene duplications or mutations. They represent about 20% of all cases with a clinical PMD phenotype. The M6b gene has been localized to Xp22.2. The encoded M6B protein is a member of a novel proteolipid family that also includes other major brain myelin components like the proteolipid protein (PLP). Recent cotransfection experiments suggest a protein-protein interaction of M6B and mutant PLP1 that may contribute to oligodendrocyte dysfunction in PMD. Therefore, M6b has been considered a good candidate gene for Pelizaeus-Merzbacher-like syndrome. However, our molecular analyses in eight thoroughly characterized patients make it unlikely that mutations in this gene are involved in this subgroup of human hypomyelination disorders.

Original languageEnglish
Pages (from-to)156-158
Number of pages3
JournalAmerican Journal of Medical Genetics
Issue number2
Early online date11 May 2004
Publication statusPublished - 15 Jul 2004
Externally publishedYes


Dive into the research topics of 'Mutation analysis of the M6b gene in patients with Pelizaeus-Merzbacher-like syndrome'. Together they form a unique fingerprint.

Cite this